In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on Agrify (AGFY – Research Report), with a price target of $4.00. The company’s shares opened today at $1.56.
Vendetti covers the Healthcare sector, focusing on stocks such as Cutera, ReShape Lifesciences, and Biolase. According to TipRanks, Vendetti has an average return of 3.1% and a 36.64% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Agrify with a $8.67 average price target.
See Insiders’ Hot Stocks on TipRanks >>
AGFY market cap is currently $41.75M and has a P/E ratio of (0.93).
Based on the recent corporate insider activity of 6 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of AGFY in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Agrify Corp provides hardware and software to grow solutions for the indoor agriculture marketplace. The products offered by the company include Integrated Grow Racks, LED Grow Lights, Hydroponics, and Vertical Farming Units.
Read More on AGFY:
